Sign In
Buy LMAT
$91.64
+0.0200 (+0.0218%)
At Close: Jun 03, 2026
LeMaitre Will Announce Third Quarter 2025 Earnings Results on November 6, 2025
05:53pm, Thursday, 09'th Oct 2025
BURLINGTON, Mass., Oct. 09, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its third quarter 2025 financial results on Thursday, November 6, 2025,
LeMaitre Vascular: Investment Debate Remains In Place
11:50pm, Monday, 15'th Sep 2025
LeMaitre Vascular remains a long-term compounder, delivering strong Q2 results with 15% sales growth, robust margins, and increased dividends. LMAT's investment thesis is supported by pricing power, a
LeMaitre to Participate at Upcoming Investor Conferences in September
04:35pm, Thursday, 28'th Aug 2025
BURLINGTON, Mass., Aug. 28, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will participate in four upcoming investor conferences.
Is LeMaitre (LMAT) a Solid Growth Stock? 3 Reasons to Think "Yes"
01:45pm, Wednesday, 27'th Aug 2025
LeMaitre (LMAT) possesses solid growth attributes, which could help it handily outperform the market.
Trump Wins
09:48am, Thursday, 21'st Aug 2025
I like that Telus is deleveraging, and I'll be following how much revenue the co-location of cell towers could bring to the table now that Telus's tower network is half-owned by a third party. I see l
LeMaitre (LMAT) is an Incredible Growth Stock: 3 Reasons Why
01:46pm, Monday, 11'th Aug 2025
LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
LeMaitre (LMAT) Q2 Revenue Jumps 15%
01:09am, Wednesday, 06'th Aug 2025
LeMaitre (LMAT) Q2 Revenue Jumps 15%
LeMaitre Vascular, Inc. (LMAT) Q2 2025 Earnings Call Transcript
12:10am, Wednesday, 06'th Aug 2025
LeMaitre Vascular, Inc. (NASDAQ:LMAT ) Q2 2025 Earnings Conference Call August 5, 2025 5:00 PM ET Company Participants David B. Roberts - President & Director Dorian LeBlanc - Chief Financial Officer
LeMaitre Vascular (LMAT) Beats Q2 Earnings and Revenue Estimates
07:16pm, Tuesday, 05'th Aug 2025
LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.6 per share, beating the Zacks Consensus Estimate of $0.57 per share. This compares to earnings of $0.52 per share a year ago.
LeMaitre Q2 2025 Financial Results
04:05pm, Tuesday, 05'th Aug 2025
BURLINGTON, Mass., Aug. 05, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq: LMAT), a provider of vascular devices, implants, and services, today reported Q2 2025 results, announced a quarter
PAHC vs. LMAT: Which Stock Should Value Investors Buy Now?
12:41pm, Monday, 04'th Aug 2025
Investors with an interest in Medical - Products stocks have likely encountered both Phibro Animal Health (PAHC) and LeMaitre Vascular (LMAT). But which of these two stocks presents investors with the
LeMaitre Will Announce Second Quarter 2025 Earnings Results August 5, 2025
04:04pm, Tuesday, 08'th Jul 2025
BURLINGTON, Mass., July 08, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2025 financial results on Tuesday, August 5, 2025, af
Don't Be Too Cute, Buy These 3 Dividend Growers Instead
07:00am, Sunday, 29'th Jun 2025
We avoid very high-yielding stocks, as the best way to grow richer over time is to own a diversified basket of dividend growth stocks. Today, we're highlighting a leading alternative asset manager, a
LeMaitre Vascular: Scaling Nicely As Global Demand Builds
07:55am, Tuesday, 17'th Jun 2025
LeMaitre's revenue and earnings continue to grow, though profit growth has moderated. The European launch of Artegraft and pending approval of XenoSure in China are key near-term catalysts. The portfo
LeMaitre to Present at the Bank of America Securities 2025 Healthcare Conference
04:39pm, Monday, 05'th May 2025
BURLINGTON, Mass., May 05, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that David Roberts, President, will present at the Bank of America Securities 2025 Healthcare
